LeMaitre Vascular Inc (LMAT):製品パイプライン分析

◆英語タイトル:LeMaitre Vascular Inc (LMAT) - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010035
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月26日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular procedures, which include balloon catheters, carotid shunts, powered phlebectomy, laparoscopic cholecystectomy devices, manual contrast injectors, modeling catheters, radiopaque tape, remote endarterectomy devices, valvulotomes, vascular grafts, vascular patches, vein strippers and vessel closure systems. LeMaitre Vascular sells its products through direct sales force in North America, Europe, Japan, China and Australia and through distributors in other geographies. The company operates sales offices in Tokyo, Japan; Mississauga, Canada; Madrid, Spain; Milan, Italy; Shanghai, China; and North Melbourne, Australia. LeMaitre Vascular is headquartered in Burlington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company LeMaitre Vascular Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
LeMaitre Vascular Inc Company Overview 4
LeMaitre Vascular Inc Company Snapshot 4
LeMaitre Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview 4
LeMaitre Vascular Inc – Pipeline Analysis Overview 6
Business Description 6
LeMaitre Vascular Inc – Key Facts 7
LeMaitre Vascular Inc – Major Products and Services 8
LeMaitre Vascular Inc Pipeline Products by Development Stage 11
LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status 13
LeMaitre Vascular Inc Pipeline Products Overview 15
Angioscope 15
Angioscope Product Overview 15
Elongated AnastoClip GC 16
Elongated AnastoClip GC Product Overview 16
XenoSure Biologic Vascular Patch 17
XenoSure Biologic Vascular Patch Product Overview 17
XenoSure Biologic Vascular Patch Clinical Trial 18
LeMaitre Vascular Inc – Key Competitors 19
LeMaitre Vascular Inc – Key Employees 20
LeMaitre Vascular Inc – Key Employee Biographies 21
LeMaitre Vascular Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
LeMaitre Vascular Inc, Recent Developments 24
Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%) 24
Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 24
Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 25
Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 25
Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 25
Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 26
May 02, 2016: LeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%) 27
Feb 24, 2016: LeMaitre Q4 2015 Record Sales $20.5mm (+14% organic), Record Net Income $2.5mm (+32%) 27
Oct 27, 2015: LeMaitre Q3 2015 Sales $19.0mm (+12% organic), Record Op. Inc. $3.3mm (+79%) 28
Sep 09, 2015: LeMaitre Vascular Hires Michael Wijas Vice President of Sales for the Americas 29
Appendix 30
Methodology 30
About GlobalData 32
Contact Us 32
Disclaimer 33

List of Tables
LeMaitre Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview 4
LeMaitre Vascular Inc Pipeline Products by Equipment Type 4
LeMaitre Vascular Inc Pipeline Products by Indication 5
LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status 5
LeMaitre Vascular Inc, Key Facts 7
LeMaitre Vascular Inc, Major Products and Services 8
LeMaitre Vascular Inc Number of Pipeline Products by Development Stage 11
LeMaitre Vascular Inc Pipeline Products Summary by Development Stage 12
LeMaitre Vascular Inc Ongoing Clinical Trials by Trial Status 13
LeMaitre Vascular Inc Ongoing Clinical Trials Summary 14
Angioscope - Product Status 15
Angioscope - Product Description 15
Elongated AnastoClip GC - Product Status 16
Elongated AnastoClip GC - Product Description 16
XenoSure Biologic Vascular Patch - Product Status 17
XenoSure Biologic Vascular Patch - Product Description 17
XenoSure Biologic Vascular Patch - Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair 18
XenoSure Biologic Vascular Patch - Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Peripheral Vascular Repair 18
LeMaitre Vascular Inc, Key Employees 20
LeMaitre Vascular Inc, Key Employee Biographies 21
LeMaitre Vascular Inc, Subsidiaries 22
Glossary 31

★海外企業調査レポート[LeMaitre Vascular Inc (LMAT):製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Continental AG:戦略・SWOT・企業財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Endesa SA (ELE):電力:M&Aディール及び事業提携情報
    Summary Endesa SA (Endesa), a subsidiary of Enel SpA, is an electric utility. It generates, distributes, and sells electricity. The company produces electricity in hydro, thermal, nuclear, combined cycle, and renewable and cogeneration plants. Endesa also supplies electricity and gas, and provides o …
  • Immucor, Inc.:企業の戦略的SWOT分析
    Immucor, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • BioLight Israeli Life Sciences Ltd (BOLT):医療機器:M&Aディール及び事業提携情報
    Summary BioLight Israeli Life Sciences Ltd (Bio-Light), formerly Bio Light Israeli Life Sciences Investments Ltd is an ophthalmic company that discovers, develops and commercializes products and product candidates for various ophthalmic conditions. The company invests in managing and commercializing …
  • Pakistan Services Ltd.
    Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • HRG Group, Inc. (HRG):企業の財務・戦略的SWOT分析
    HRG Group, Inc. (HRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bio Techne Corp (TECH):製薬・医療:M&Aディール及び事業提携情報
    Summary Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoa …
  • China Development Bank
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mustek Limited (MST):企業の財務・戦略的SWOT分析
    Mustek Limited (MST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Middlesex Water Company (MSEX):企業の財務・戦略的SWOT分析
    Summary Middlesex Water Company (Middlesex Water) is a provider of water utility services. The company's services include water production, treatment and distribution, regulated and non-regulated water and wastewater utility services, wastewater system maintenance and working to promote economic dev …
  • Massilly Holding S.A.:企業の戦略・SWOT・財務分析
    Massilly Holding S.A. - Strategy, SWOT and Corporate Finance Report Summary Massilly Holding S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Synthos SA:企業の戦略的SWOT分析
    Synthos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Diffusion Pharmaceuticals Inc (DFFN):製薬・医療:M&Aディール及び事業提携情報
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Israel Aerospace Industries Ltd:戦略・SWOT・企業財務分析
    Israel Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Israel Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Filtronic plc:企業の戦略・SWOT・財務分析
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • BHP:企業のM&A・事業提携・投資動向
    BHP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BHP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, …
  • Dev Information Technology Ltd (DEVIT):企業の財務・戦略的SWOT分析
    Dev Information Technology Ltd (DEVIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • LifeNet Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeNet Health Inc (LifeNet Health) is a non-profit organization that specializes in regenerative medicine. It offers allograft bio-implants and organs for transplantation. The organization specializes in offering organ procurement, tissue banking and transplant services. It provides allogra …
  • McBride plc (MCB):企業の財務・戦略的SWOT分析
    McBride plc (MCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tupras (Turkish Petroleum Refineries Co):企業の戦略・SWOT・財務分析
    Tupras (Turkish Petroleum Refineries Co) - Strategy, SWOT and Corporate Finance Report Summary Tupras (Turkish Petroleum Refineries Co) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆